Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

2.
3.

New oral anticoagulants: comparative pharmacology with vitamin K antagonists.

Scaglione F.

Clin Pharmacokinet. 2013 Feb;52(2):69-82. doi: 10.1007/s40262-012-0030-9. Review.

PMID:
23292752
4.

Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants.

Wharin C, Tagalakis V.

Blood Rev. 2014 Jan;28(1):1-8. doi: 10.1016/j.blre.2013.11.001. Epub 2013 Nov 28. Review.

PMID:
24360911
5.

Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.

Beyer-Westendorf J, Ageno W.

Thromb Haemost. 2015 Feb;113(2):231-46. doi: 10.1160/TH14-06-0484. Epub 2014 Oct 16. Review.

PMID:
25319150
6.

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients.

Gerotziafas GT, Mahé I, Elalamy I.

Ther Clin Risk Manag. 2014 Jun 13;10:423-36. doi: 10.2147/TCRM.S49063. eCollection 2014. Review.

7.

New oral anticoagulants in the treatment of acute venous thromboembolism - a systematic review with indirect comparisons.

Hirschl M, Kundi M.

Vasa. 2014 Sep;43(5):353-64. doi: 10.1024/0301-1526/a000373. Review. Erratum in: Vasa. 2014 Nov;43(6):477.

PMID:
25147012
8.

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis.

van der Hulle T, Kooiman J, den Exter PL, Dekkers OM, Klok FA, Huisman MV.

J Thromb Haemost. 2014;12(3):320-8. doi: 10.1111/jth.12485. Review.

9.

Use of New Oral Anticoagulants in the Treatment of Venous Thromboembolism and Thrombotic Prophylaxis.

Akin M, Schäfer A, Akin I, Widder J, Brehm M.

Cardiovasc Hematol Disord Drug Targets. 2015;15(2):92-6. Review.

PMID:
26666324
10.

Long-term benefits of preventing venous thromboembolic events.

Cohen AT.

Curr Med Res Opin. 2012 Jun;28(6):877-89. doi: 10.1185/03007995.2012.688737. Epub 2012 May 24. Review. Erratum in: Curr Med Res Opin. 2012 Sep;28(9):1574. Dosage error in article text.

PMID:
22533680
11.

New anticoagulants: focus on venous thromboembolism.

Gómez-Outes A, Lecumberri R, Pozo C, Rocha E.

Curr Vasc Pharmacol. 2009 Jul;7(3):309-29. Review.

PMID:
19601856
12.

The current landscape of treatment options for venous thromboembolism: a focus on novel oral anticoagulants.

Hull RD, Gersh MH.

Curr Med Res Opin. 2015 Feb;31(2):197-210. doi: 10.1185/03007995.2014.975786. Epub 2014 Oct 30. Review.

PMID:
25299352
13.

Venous thromboembolism management: where do novel anticoagulants fit?

Spyropoulos AC, Turpie AG.

Curr Med Res Opin. 2013 Jul;29(7):783-90. doi: 10.1185/03007995.2013.803462. Epub 2013 May 28. Review.

PMID:
23659584
14.

Direct oral anticoagulants in the prevention of venous thromboembolism: evidence from major clinical trials.

Prandoni P, Temraz S, Taher A.

Semin Hematol. 2014 Apr;51(2):121-30. doi: 10.1053/j.seminhematol.2014.03.006. Epub 2014 Mar 29. Review.

PMID:
24861796
15.

Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.

Rollins BM, Silva MA, Donovan JL, Kanaan AO.

Clin Ther. 2014 Oct 1;36(10):1454-64.e3. doi: 10.1016/j.clinthera.2014.06.033. Epub 2014 Aug 3.

PMID:
25092394
16.

New anticoagulants in the treatment of VTE.

Le Gal G, Mottier D.

Semin Respir Crit Care Med. 2012 Apr;33(2):191-8. doi: 10.1055/s-0032-1311799. Epub 2012 May 30. Review.

PMID:
22648492
17.

Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism.

van der Hulle T, den Exter PL, Kooiman J, van der Hoeven JJ, Huisman MV, Klok FA.

J Thromb Haemost. 2014 Jul;12(7):1116-20. doi: 10.1111/jth.12605. Epub 2014 Jun 19.

18.

New oral anticoagulants for the treatment of venous thromboembolism.

Agnelli G, Becattini C, Franco L.

Best Pract Res Clin Haematol. 2013 Jun;26(2):151-61. doi: 10.1016/j.beha.2013.07.005. Epub 2013 Jul 22. Review.

PMID:
23953903
19.

Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.

Cheng JW, Barillari G.

J Clin Pharm Ther. 2014 Apr;39(2):118-35. doi: 10.1111/jcpt.12122. Epub 2014 Jan 3. Review.

PMID:
24383983
20.

Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?

Laux V, Perzborn E, Heitmeier S, von Degenfeld G, Dittrich-Wengenroth E, Buchmüller A, Gerdes C, Misselwitz F.

Thromb Haemost. 2009 Nov;102(5):892-9. doi: 10.1160/TH09-02-0134. Review.

PMID:
19888525

Supplemental Content

Support Center